| Involved Organisation | Type | Further fields of acitivity | Focus | based in | Management | was foundet in | Address | Homepage | Profile | Contact | Number of employees | Certificates | BioChancePlus | BioProfile | Scientific Advisory Board | Advisory Board | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ExploSys | Biotech | Development, Information Technology | Simulation of biological systems | Leinfelden-Echterdingen | PD Dr. Martin Eichner Dr. Hans-Peter Duerr Dr. Markus Schwehm | 2005 | Westbahnhofstrasse 55 72070 Tübingen Germany Tel.: +49 (0)7071-2978250 Fax: +49 (0)7071-295383 | info@explosys.de | www.explosys.de | The three Explosys scientists work on the basis that even seemingly simple problems in public health are caused by complex, interacting factors and thus require customised solutions. Using mathematical models and computer simulations, they aim to create innovative and flexible solutions for precisely such problems. Of course, such models are also intended to advance fundamental research into epidemiological modelling. Realistically-simulated infection outbreaks are intended to train physicians and people in positions of responsibility in how to bring potential epidemics under control through fast and efficient intervention. “InterSim” is a computer model that can authentically simulate the progress of a spreading infection. It enables recommendations to be derived for decision-makers, for example, those in public health roles. InterSim has since received multiple awards, including the “Special Prize for Open Source Software” in October 2004 from the Business Initiative Baden-Württemberg: connected (bwcon). A simulator, based on InterSim, was developed following a commission from the BGMS (German Federal Ministry of Health and Social Security) and is currently being used by the Robert Koch Institute to develop efficient interventional strategies for epidemics. The "Influenza-Pandemic-Planning-Simulator" InfluSim enables the prediction of the temporal course of an influenza pandemic. The software can be downloaded from http://www.uni-tuebingen.de/modeling/Mod_Pub_Software_de.html. | Dr. Markus Schwehm (Markus.Schwehm@explosys.de) | K. Auranen K. Dietz G. Sallet A. Spielman | |||||
| M-fold Biotech GmbH | Biotech | Development, Proteomics | Structural analyses, in vitro bonding and functional testing of membrane proteins, production of antibodies | Tübingen | Dr. Hans Kiefer, Scientific Director Dr. Wolfgang Vogt, Managing Director | 1999 | Vor dem Kreuzberg 17 72070 Tübingen Germany Tel.: +49 (0)7071-7945-0 Fax: +49 (0)7071-7945-11 | contact@m-phasys.com | www.m-phasys.com | M-fold Biotech was founded in 1999 as m-phasys by Dr. Hans Kiefer, Dr. Wolfgang Vogt, Marc Lohrmann and i.con. innovation GmbH. Membrane proteins are the most commercially-interesting target proteins for medications and represent M-fold Biotech GmbH’s core area of expertise yet they are also the most difficult to work with. The key to the firm’s success was the use of the patented M-FOLD technology, which was used to manufacture membrane protein antigens. Using two very different methods (immunisation and “phage display” selection), the firm succeeded in manufacturing antibodies with the required binding properties and biological activity and selectivity. In addition to structural analysis, m-phasys has recently established a new area of business, namely the manufacture of antibodies that act against membrane proteins and can themselves act as medications. M-fold Biotech's customers include major pharmaceutical companies who commission the structural analyses in order to develop medications. | 12 | Structural explanations of therapeutically-relevant potassium channels | Associated project: Joint project into the generation of antibodies against frizzled receptors (GPCRs) for the isolation and characterisation of stem cells. | ||||
| Hölle & Hüttner AG | Biotech | Laboratory Techniques, Information Technology, Process Engineering | Information technology – optimisation of processes and products and subsequent improvement in companies’ ability to deliver quality | Tübingen | Dr. Steffen Hüttner Peter Beck | 1992 | Derendinger Strasse 40 72072 Tübingen Germany Tel.: +49 (0)7071-9761-1 Fax: +49 (0)7071-9761-90 | lifescience@h-net.com | www.h-net.com | Hölle & Hüttner AG specialises in the implementation of new technologies and complex issues in science and technology-related projects. Hölle & Hüttner’s portfolio embraces more than 300 projects in over 10 countries. Hölle & Hüttner AG is a pioneer in the combination of life sciences and information technology, aimed at automating workflows. Its areas of focus lie in laboratory information and production systems, control software, the operation of laboratory equipment, integration issues, archiving and document management based on established standards. Hölle & Hüttner AG’s headquarters are located in Tübingen, while the firm has branch offices in Munich, Cologne, Manchester (UK) and Houston (USA). | Dr. Steffen Hüttner | 26 | QM system compliant with ISO 9001ff | Effects of heat-shock proteins (HSP) on wound healing | |||
| BioTeSys GmbH | Biotech | Development, Drug Development, Diagnostics | Analysis of the biological function of active ingredients | Esslingen | Dr. Jürgen Bernhardt (CEO) Dr. Karin Engelhart (CSO) Consuelo Gallardo (COO) | 1999 | Schelztorstrasse 54-56 73728 Esslingen Germany Tel.: +49 (0)711-31057150 Fax: +49 (0)711-31057151 | bts@biotesys.de | www.biotesys.de | BioTeSys was founded in 1999 as a spin-off of the Institute of Biological Chemistry and Nutritional Science at the University of Hohenheim and has moved to the LSC (Life Science Centre) in Esslingen. BioTeSys has established and expanded three areas of expertise for its commercial activities. These include: Analysis, whose techniques are deployed either independently or in concert with others; Cell and Tissue Culture, complete with its associated testing options and Services for Clinical Trials (applications, monitoring, coordination etc.). The company’s own research focuses primarily on micronutrients and their enrichment for regenerating biological systems. BioTeSys uses nanoparticles as a new and smart means of transport for encapsulating active ingredients and addressing them so that they exert their effect directly on the target organ. This reduces the quantity of active ingredient in the body and avoids putting strain on the organism as a whole. Commissioned by Pascoe Pharmazeutische Präparate GmbH, BioTeSys developed a kit for determining micronutrients. This kit currently enables the presence of vitamin C, the E vitamins, ß-carotene and lycopene to be detected in swabs taken from oral mucosal tissue. | Dr. Jürgen Bernhardt (j.bernhardt@biotesys.de) | 14 | Nutritargeting: highly-selective enrichment strategies for the regeneration of biological systems | ||||
| novineon Healthcare Technology Partners GmbH | Biotech | Development, Nutrigenomics | Consulting and research in the field of healthcare technology | Tübingen | Prof. Marc O. Schurr (Managing Director) | 2001 | Dorfackerstrasse 26 72074 Tübingen Germany Tel.: +49 (0)7071-7704514 Fax: +49 (0)7071-763574 | info@novineon.com | www.novineon.com | novineon operates in all sectors of the healthcare industry. The consulting firm, with its international network, supports manufacturers and users of medical products and services in all aspects of development, trials and marketing. Its research activities – including both its own and commissioned research – focus on the development, trial and validation of new technologies in medicine and ranges from the development of concepts and prototyping to the medical trials of prototypes and validation of the new product. The company also holds shares in newcomers to the industry and supports them as they turn their technologies into marketable products. | Joint research project: Tissue engineering with entodermal stem cells and the development of endoscopic technologies for the removal of such cells from the colon | ||||||
| SOURCON-PADENA GmbH & Co. KG | Biotech | Development, Ecology/Environment, Trade/Distribution | Developing, manufacturing and marketing biological active agents to protect agricultural crops from pests. | Tübingen | Hilke Arndt (CEO and founder) | 2000 | Hechinger Strasse 262 72072 Tübingen Germany Tel.: +49 (0)7071-97552-0 Fax: +49 (0)7071-97552-50 | info@sourcon-padena.de | www.sourcon-padena.de | SOURCON-PADENA was founded in April 2000 as a joint-stock company (AG) from two private enterprises. The two original companies were spin-offs from the Universities of Stuttgart-Hohenheim and Tübingen. In May 2001, SOURCON-PADENA won Buck Chemie GmbH of Herrenberg, Germany, as a partner by acquiring a minority stake in the company. SOURCON-Padena's core expertise lies in the isolation, cultivation and extraction of micro-organisms as delivery media for active substances. Using quality control procedures in accordance with HPLC-MS, the company supplies high-quality extracts to search for active substances that are free from disrupting factors and are proven to contain new substances that were previously not accessible through conventional methods. The company also specialises in fermentation technologies and offers these at pilot-plant scale up to 200 litres (S1). The company's PRORADIX® plant strengthener, which effectively protects agricultural crops against pests in harmony with nature, is already marketed in the agricultural sector. The active agent is a natural soil bacterium that surrounds the roots of agricultural crops and can function from there without interfering with the ecosystem in the long term. | Associated project NAPRAS; Development of new agents against biofilm formation on regenerative and synthetic tissue implants; Subproject 1: Isolation and identification of the active agents | ||||||
| PANATecs GmbH | Biotech | Development, Medicine, Nutrigenomics, Diagnostics | Provision of bioanalytical services, particularly mass spectrometry-based, for the pharmaceutical, foodstuffs and animal feed industries. Manufacture and sale of bioanalytical substances for research (e.g. peptides, antibodies, marker reagents etc.). | Tübingen | Dr. Thomas Flad, Pharmacist (CSO) Alexander Cansier (COO) | 2004 | Ob dem Himmelreich 7 72074 Tübingen Germany Tel.: +49 (0)7071-29720-93, -94 and -95 Fax: + 49 (0)7071-294445 | info@panatecs.com | www.panatecs.com | PANATecs GmbH was founded in 2004 as a spin-off of the University of Tübingen. Its founding partners are Prof. Claudia Müller (Transplantation Immunology and Immunohaematology Section, “Medizinische Klinik und Poliklinik”, Dept. II), Prof. Gerhard A. Müller (Nephrology & Rheumatology Department, Centre for Internal Medicine, Georg August University, Göttingen), Dr. Hubert Kalbacher (University of Tübingen, Physiological Chemistry Institute (PCI), Medical and Scientific Research Centre, University of Tübingen) and the two Managing Directors Dr. Thomas Flad and Alexander Cansier. In addition to the production of bioanalytical products and the conducting of specialist analyses, PANATecs GmbH also carries out its own research projects. In collaboration with major partners, the firm handles projects from the field of clinical mass spectrometry. The aim of these research activities is to develop new, mass spectrometry-based diagnostic methods for the early detection of autoimmune and cancer-related diseases. | Alexander Cansier | 12 | Development of new tests for the molecular diagnosis of rheumatoid arthritis | ||||
| CenTrial GmbH | Biotech | Medicine | Contract research, CRO, services in clinical studies, training | Tübingen | Professor Christoph H. Gleiter (CEO) Dr. Armin Bauer (Project Manager) | 2000 | Otfried-Müller-Strasse 45 72076 Tübingen Germany Tel.: +49 (0)7071-2972262 Fax: +49 (0)7071-295158 | sekretariat.kks@kks-tu.de | www.kks-tu.de | CenTrial, a joint venture by the University Hospitals of Tübingen and Ulm, offers support in a CRO role in cooperation with study managers from the hospital, clinical practices, contract research institutes and industry in accordance with national and international standards. The studies are carried out to high levels of clinical, statistical methodological, technical and ethical quality, and are of high calibre with regard to health economics. CenTrial welcomes all studies and works with departments at the University Hospitals of Tübingen and Ulm, other study centres, affiliated physicians and industry partners. Through this network, CenTrial can provide a full spectrum of services, either individually or as all-in-one solutions. CenTrial was founded in December 2000 as an affiliated company of the University Hospital of Tübingen. Since 1 January 2006, CenTrial has been an affiliated company of the University Hospitals of Tübingen and Ulm. | Professor Christoph H. Gleiter | 40 | Quality management system/certification to DIN EN ISO 9001:2000 Quality assurance in accordance with ICH-GCP | ||||
| Fraunhofer-Institut für Grenzflächen- und Bioverfahrenstechnik IGB | Institute | Development, Medicine, Chemistry, Process Engineering | The creation of solutions for business and public clients in the fields of health, the environment and technology | Stuttgart | Prof. Dr. Thomas Hirth (Institute Director) | 1952 | Nobelstrasse 12 70569 Stuttgart Germany Tel.: +49 (0)711-9704001 Fax: +49 (0)711-9704200 | info@igb.fraunhofer.de | www.igb.fraunhofer.de | IGB’s roots go back to 1952, the year in which the Institute of Surface Physics and Chemistry was founded. The Institute was taken over in 1962 by the Fraunhofer Society. The Institute was given its present name in 1976, coinciding with the creation of the research fields involving bioprocess technology and membrane technology. The Fraunhofer IGB is one of six Fraunhofer institutes in Stuttgart, the Fraunhofer Society’s largest location. The IGB’s main areas of expertise include surface technology, membrane technology, biotechnology, cell system technology and bioprocess technology. The IGB offers its clients full-service solutions, ranging from market analysis and research to ready-to-use development. The scientists working at the IGB focus on various disciplines – from physics, chemistry, biology and molecular biology to engineering-related sciences. Their goal is to translate biological and biochemical problems and challenges in product preparation and environmental technology into commercially-attractive and environmentally-friendly processes and products. The IGB’s core areas of research are handled in four divisions, each focusing on different areas of application or business. 1) The “Molecular Substances for Pharmaceuticals and Chemical Industries” division focuses primarily on the development of therapeutic proteins and target screening, diagnostic methods using biochips and diagnostic agents, biocatalysis and enzyme screening, fermentation, downstream processing and scale-up production. The second division focuses on the development of 3-dimensional, organoid cell structures as test systems, tissue engineering and manufacturing based on GMP guidelines. In the “Functional Surfaces and Membranes” division, the scientists primarily work on surface-dominated polymers, biomaterials and biomimetic surfaces, together with the design of new membranes. The Fraunhofer IGB’s fourth division is devoted to biotechnical environmental rehabilitation, the recycling of organic waste, waste water purification and water management and the regenerative production of materials using microalgae. In addition to this purely R&D-based activity, the Fraunhofer IGB also offers services in various sectors such as analysis, molecular biology, cell biology and commissioned research into cell therapy agents based on GMP. | Dr. Claudia Vorbeck (claudia.vorbeck@igb.fraunhofer.de) | 140 | Accreditation to DIN EN ISO/IEC 17025 for HPCL, IC, GPC, GC and GC/MS, ESCA; GMP unit and manufacturing permit for autologous chondrocyte transplants (others have been applied for). | ||||
| STRATEC Biomedical Systems AG | Biotech | Development, Information Technology, Process Engineering | STRATEC Biomedical Systems AG plans, develops and produces fully-automatic analysis systems for partners from the field of clinical diagnostics and life sciences using its own, patent-protected technologies. | Birkenfeld | Hermann Leistner (Board Chairman) Marcus Wolfinger (CFO) Bernd M. Steidle (Director of Sales and Marketing) | 1979 | Gewerbestrasse 37 75217 Birkenfeld Germany Tel.: +49 (0)7082-79160 Fax: +49 (0)7082-7916999 | info@stratec-biomedical.de | www.stratec-biomedical.de | Founded in 1979 as STRATEC Elektronik GmbH, the company focused in 1994 on the core areas of OEM (Original Equipment Manufacturer) development and the production of integrated solutions for international manufacturers of diagnostic agents. STRATEC products have enjoyed success especially in the growth sectors of laboratory diagnostics and life sciences. Based on its existing product platforms, STRATEC develops innovative, customer-focused products with an effective cost structure and within a period of 18 to 36 months. STRATEC offers a first-rate full service and provides its entire range of instruments from a single source, drawing on a broadly-based pool of technologies including: liquid handling systems, software, robotics and detection modules, process validation, documentation services and approval services. New technologies are continuously being developed in the field of diagnostics and life sciences accompanied by changes in regulations so that processes must constantly be adapted to their specific environment. STRATEC meets all these challenges by supporting its customers’ instrumentation activities in the field of project management, hardware and software engineering, verification and production. With experience spanning over 25 years and an in-depth knowledge of technology and the regulations governing it, STRATEC offers its partners valuable support in all phases of the system life cycle. STRATEC’s development and production facilities are based on its own, patent-protected technologies and focus on integrated solutions. The company’s partners are skilled in market knowledge and specific reagent expertise while STRATEC provides expertise and application know-how in natural and engineering sciences as well as in automation and application software. | Bernd M. Steidle (b.steidle@stratec-biomedical.de) | 183 | DIN EN ISO 9001, DIN EN ISO 13485, FDA-registered , CSA/UL-registered | ||||
| Institut Prof. Dr. Jäger | Biotech | Chemistry, Ecology/Environment, Laboratory Techniques | Environmental analysis | Tübingen | Dr. Walter Jäger | 1977 | Ernst-Simon-Strasse 2-4 72072 Tübingen Germany Tel.: +49 (0)7071-70070 Fax: +49 (0)7071-700777 | Institut@institutdrjaeger.de | www.institutdrjaeger.de | The laboratory’s main area of focus lies on chromatographic analysis methods (GC, LC, HPLC) and in particular the determination of halogenated aliphats, aromates, phenolic compounds and so on as single substances (PCP, PCB, HCB, pesticides, etc.) and as sum parameters (AOX, EOX, AOS, TON, TOP, TOSI etc.), the taking of samples and the analysis of dioxins and furanes. The company is based in Tübingen, with field offices in Konstanz, Villingen-Schwenningen and Weimar. | Approx. 65 | All required quality assurance certificates | |||||
| Synovo GmbH | Biotech | Development, Drug Development, Medicine | Testing methods for choosing drug candidates | Tübingen | Dr. Michael Burnet (CEO) | Paul-Ehrlich-Strasse 15 72076 Tübingen Germany Tel.: +49 (0)7071-964325 Fax +49 (0)7071-964326 | contact@synovo.com | www.synovo.com | Synovo GmbH is a pharmaceutical research company that offers services in the fields of synthetic chemistry, pharmacology, cell engineering and peptide modification. The company’s focus lies in providing various testing methods and models – ideally using human cells, proteins or systems – for the selection of drug candidates with improved properties in terms of absorption, distribution, metabolism and elimination (ADME or DMPK). On behalf of customers from the pharmaceutical industry, Synovo is involved in projects investigating anti-inflammatory and immuno-suppressive drug optimisation and the improvement of existing technologies used for the development of new drugs from proteins and nucleic acids. This work is carried out in collaboration with public-sector laboratories. | Dr. Michael Burnet | 20 | ||||||
| biotask AG | Biotech | Nutrigenomics | Analytical and consulting services for nutrition management, the animal feed industry and the agricultural/pharmaceutical industry | Esslingen | Prof. Bärbel Kniel (Director) Maximilian Moser (Director) | 2000 | Schelztortrasse 54-56 73728 Esslingen Germany Tel.: +49 (0)711-31059060 Fax: +49 (0)711-31059070 | max.moser@biotask.de | www.biotask.de | The key areas of the services provided by biotask AG include the analysis and interpretation of analysed results, together with appropriate consulting and customer support. This includes the conduction of sample analyses using chromatographic and molecular biology methods, customer-specific consulting involving quality assurance, development, purchasing and production, plus support for the procurement of raw materials, the setup and expansion of quality assurance systems and laboratory automation. | 8 | ||||||
| IP-Innovatives Planen-GmbH | Biotech | Medical Technology, Process Engineering | Clean-room planning | Neckartenzlingen | Christian Hage (Managing Director) | 1992 | Robert-Bosch-Strasse 15 72654 Neckartenzlingen Germany Tel.: +49 (0)7127-9370-3 Fax: +49 (0)7127-9370-55 | info@ip-planung.de | www.ip-planung.de | IP-Innovatives Planen-GmbH specialises in the planning of clean-room plants and technical equipment for buildings, from design to start-up. The company integrates modern ventilation concepts and innovative energy solutions into clean-room environments. | 15 | ||||||
| M+W Process Industries GmbH | Biotech | Medical Technology, Chemistry, Trade/Distribution, Laboratory Techniques | Planners and systems engineers specialising in the life sciences industry | Stuttgart | Hermann Schwarzkopf (Managing Director) Dr. Tobias Lücke (Managing Director) | 1995 | Lotterbergstrasse 30 70499 Stuttgart Germany Tel.: +49 (0)711-8804-1800 Fax: +49 (0)711-8804-1888 | www.mwgroup.net | Stuttgart-based M+W Process Industries GmbH -formerly LSMW GmbH- is a planner and systems engineer which specializes in the requirements of the life sciences industry. It offers solutions for large, medium-sized and start-up companies in the pharmaceuticals, biotechnology, fine chemicals, chemical, medical products, foodstuffs and cosmetics industries. The company’s range of services comprises consulting, planning, implementation, qualification/validation and technical facility management for the construction of new or conversion of existing buildings. | 344 (as of Jan. 2007) | |||||||
| Blessing Biotech GmbH | Biotech | Nutrigenomics | Fermentation biotechnology services | Stuttgart | Jörg Groth (groth@blessing-biotech.de) Doris Scharf | 2005 | Leobener Strasse 71 70469 Stuttgart Tel.: +49 (0)711-8999-470 Fax.: +49 (0)711-8999-400 | info@blessing-biotech.de | The company began life in 1989 as BITEC, a production division of Gewürzmüller, in the form of a new plant for starter culture production. In 2005, the production division was hived off to form BLESSING Biotech GmbH and has since operated as an independent company. In October 2007, Frutarom Industries Ltd. (Israel) signed an agreement to acquire 100% of the share capital of the German companies Gewuerzmueller GmbH and Blessing Biotech GmbH in consideration for a cash payment of US$ 67 million (Euro 47.3 million). The company focuses in particular on manufacturing industrial-scale starter cultures (particularly lactic acid bacteria) for the foodstuffs and animal feeds industry, performing contract fermentation, and mixing and bottling biotech products. BLESSING Biotech has a comprehensive gene bank of lactic acid bacteria from which customers can assemble their products using their own formula. | 22 | |||||||
| LAZ Prof. Dr. H. Hamacher - Laboratorium für Arzneimittelprüfung und Zulassungsberatung | Biotech | Development | Quality testing of pharmaceutical source materials, finished products and packaging materials. Development and validation of testing methods. Stability analyses. | Tübingen | 1984 | Dischinger Weg 15 72070 Tübingen Germany Tel.: +49 (0)7071-791163 Fax: +49 (0)7071-791598 | LAZ-Prof.Hamacher@t-online.de | www.laz-labor.de | With over 20 years of experience, the Laboratory for Testing Medicinal Products and Registration Advice (LAZ) is a pioneer in the area of pharmaco-analytical services and has built up exceptional specialist and advisory know-how in the development and registration of medical products. Its portfolio of analytical services includes the development and validation of testing methods, the implementation of quality control measures, compatibility and stability studies for medical products, the determination of residues, the characterization/structural analysis of impurities, microbiology and bioanalytics. All services are provided in strict accordance with current national and international regulatory requirements and under GMP-compliant conditions. The consultancy services of the LAZ cover all aspects of quality assurance related to the development and registration of medical products, the creation and appraisal of documentation and the management of regulatory procedures. | 11 | |||||||
| Agenolab GmbH & Co. KG | Biotech | Development, Regenerative Biology | Speciality laboratory for bioanalytics and cell culture technology Provider of contract services and developments | Stuttgart | Dr. Andreas Greither | Kesselstrasse 17 70327 Stuttgart-Wangen Tel.: +49 (0)711-3513847 Fax: +49 (0)711-3513839 | info@agenolab.de | www.agenolab.de | Young, innovative biotechnology & life sciences company offering microbiology and molecular biology applications, tissue engineering, GMP production (§ 15 AMG), quality assurance, histology and oncology. Provider of contract services and developments using a laboratory with state-of-the-art equipment. | 10 | |||||||
| EMC microcollections GmbH | Biotech | Chemistry, Laboratory Techniques | Contract synthesis for the pharmaceuticals industry and molecular tools for biotechnology | Tübingen | Professor Karl-Heinz Wiesmüller (CEO and shareholder) Professor Günther Jung (CSO and shareholder) Dr. Friedrich Stracke (CFO and shareholder) | 1996 | Sindelfinger Str. 3 72070 Tübingen Germany Tel.: +49 (0)7071-40740 Fax: +49 (0)7071-407422 | emc@microcollections.de | www.microcollections.de | EMC microcollections GmbH was founded in 1996 and incorporated in January 2000. The company currently employs approx. 22 staff. The core areas of expertise for EMC microcollections lie in bioorganic synthesis and immunochemistry. In addition, EMC is well-renowned for establishing new strategies for pharmaceuticals development, including e.g. lead structure optimisation and analysis of organic chemical compounds. | Professor Wiesmüller | ||||||
| Tosoh Bioscience GmbH | Biotech | Chemistry, Laboratory Techniques | Media and pre-packed columns for chromatography | Stuttgart | Hiroyuki Uchida (Managing Director, Tosoh Corporation) Hiroyuki Suzuki (President, Tosoh Bioscience GmbH) Yoichi Yasuda (General Manager, Bioscience Division, Tosoh Corporation) Masayuki Yamada (President, Tosoh Bioscience Limited, Tosoh Bioscience Incorporated) | 1987 | Zettachring 6 70567 Stuttgart Germany Tel.: +49 (0)711-13257-0 Fax: +49 (0)711-13257-89 | info.sep.eu@tosoh.com | www.tosohbioscience.de | Tosoh Bioscience is an internationally-acknowledged supplier in the field of bio-separation technology. Earning its reputation under the name TosoHaas, the firm was founded in 1987 from a joint venture between the chemical group Rohm & Haas, USA and the Tosoh Corporation (founded in 1935) from Japan. In 2001, the company was renamed Tosoh Biosep. At the start of 2003, all areas of Tosoh’s Scientific Instrument Division (Separation and Diagnostics) were combined under the umbrella name Tosoh Bioscience. Tosoh Bioscience is part of the Scientific Instruments Division of the Japanese Tosoh Corporation which was founded in 1935. Tosoh Bioscience offers a wide range of media and pre-packed columns (based on silicon or polymer materials) for all common chromatography methods. These products are based on the brand products TSK-GEL®, Toyopearl® and ToyoScreen®. Tosoh Bioscience also offers modified media for customer-specific separations and technical service such as applications for research and analysis, method development and scale-up plus assistance and consulting for the packaging of large columns on site. Production facilities in Japan supply the company’s subsidiaries in the USA and Europe. | Dr. Regina Holzhauser | ||||||
| ACES Ing.-GmbH | Medtech | Medical Technology, Laboratory Techniques, Information Technology, Process Engineering | Finite Element Analysis (FEA) calculation, 3D-CAD design, product development | Filderstadt | Frank Thilo Trautwein (CEO) | Ludwigstr. 26 70794 Filderstadt Germany | info@acesgmbh.de | www.acesgmbh.de | Using calculations based on the Finite Elements Method (FEM), the properties and behaviour of materials when subjected to contact, friction, bending or bulging, non-linear material behaviour, the effects of temperature or oscillatory properties are mapped with high levels of accuracy. To carry out these services, the company has used NE/Nastran, a universal FEM code for solving structural analysis problems as its main analytical tool since 1998. 3D-CAD services are also offered for product development. 3D-CAD can be linked with CAE applications such as photo-realistic mapping, product animation, FEM calculation or rapid prototyping. ACES has experience in the fields of medical technology, electronics, software development and automation as well as vehicle technology. As a specialist in CAE applications, ACES advises on the possibilities and shortcomings of, and adaptation options for, the software being used. ACES also supports its customers in the implementation of CAE tools through software adaptations, interfaces, documentation and the programming of additional programs. | Frank Thilo Trautwein (CEO) | |||||||
| Hohenstein Institutes Bönnigheim | Institute | Development, Education | Contract research, testing, certification and consulting | Bönnigheim | Dr. Stefan Mecheels (Management) | Castle of Hohenstein 74537 Bönnigheim Tel.: +49(0)7143-2710 Fax: +49(0)7143-27151 | info@hohenstein.de | www.hohenstein.de | The Hohenstein Institutes are internationally recognised research and service centres. Companies and businesses along the entire textile chain, and in numerous other associated areas, benefit from the skills of the Hohenstein experts in research, development, testing, consulting, certification and all types of training. The core competences of the Hohenheim Institute of Hygiene and Biotechnology include: * hygiene and microbiological investigations (hygiene management) * safety testing (skin compatibility) * activity testing (antimicrobial surfaces) * efficacy testing (transfer of cosmetically and medically active substances, wound dressings) | Dr. Dirk Höfer, Head of the Institute of Hygiene and Biotechnology (d.hoefer@hohenstein.de) | |||||||
| Institut Pieldner GmbH | Biotech | Chemistry, Genomics, Education | Services in the food chemistry and food micro/molecular biology sectors | Stuttgart | Horst U. Pieldner (proprietor) | Julius-Hölder-Str. 20 70597 Stuttgart Phone: +49 (0)711 722094-0 Fax: +49 (0)711 722094-15 | info@ipdp.de | www.ipdp.de | Based in Stuttgart-Degerloch, the Institut Prof. Dr. Pieldner has been an established name in the fields of chemical, microbiological and genetic food testing for 40 years. This accredited institute supports a wide range of companies involved in the manufacture and trading of foodstuffs, cosmetics and articles of daily use. The company focuses on customised support to ensure product hygiene and uses state-of-the-art testing procedures. In addition to its role as a testing laboratory, the Institut Prof. Dr. Pieldner also offers its customers a high standard of comprehensive advice and support. This enables precise checking of compliance with complex food-law requirements and identification of any further problem areas. As well as seminars and training courses to provide information about food law, hygiene and food safety, the company also offers comprehensive on-site monitoring of workplaces throughout Germany. | Horst U. Pieldner (state-certified food chemist); Tanja Pieldner (state-certified food chemist) | |||||||
| Nexxor GmbH | Biotech | Development, Information Technology | Knowledge-oriented information systems for the life sciences, pharmaceutical and biotechnology sectors | Stuttgart | Dr. Gerhard Weber Ralf Eilbracht Stefan Kesberg | 2008 | Vollmoellerstr. 11 70563 Stuttgart Tel.: +49 (0)711-91260466 Fax: +49 (0)711-91260468 | info@nexxor.de | www.nexxor.de | Nexxor GmbH develops so-called “knowledge-oriented information systems” using its proprietary topicWorks technology, which is based on a family of semantic ISO standards. The company, which was established in 2008 by two bioinformaticians and an ecologist, designs software solutions specifically aimed at clients in the life sciences, pharmaceutical and biotechnology sectors. The software systems developed by Nexxor do not just focus on data and documents, but are also able to represent the meaning and context of database content in a flexible and meaningful way, thus making the knowledge of individual members of a cooperative project accessible to all. In addition, the software systems enable independent data sources to be linked. The technology can for example be used for the administration of a broad range of project data generated by medical, pharmacological, agricultural or ecological studies, but also for substance collections or drug information systems, as well as a broad range of biological, biochemical or physiological relationships. In many areas that use rigidly structured databases for the management of information, the new technology will greatly benefit users thanks to its high degree of flexibility and the large number of access paths that confer meanings. | |||||||
| Novalung GmbH | Medtech | Medical Technology, Regenerative Biology, Process Engineering | Development of therapies for acute and chronic lung failure | Talheim | Dr. Georg Matheis (CEO) Hannes Wetscher | 2002 | Egerten 3 74388 Talheim Tel.: +49 (0)7133-90110 Fax: +49 (0)7133-09011299 | info@novalung.com | www.novalung.com | "Solutions for Lung Failure" - this is Novalung’s philosophy. Novalung GmbH started in 2003 as the world's first company to market an artificial lung, the iLA Membrane Ventilator®, which is perfused by the heart like a natural organ. Through this reliable extrapulmonary ventilation, i.e. the removal of carbon dioxide of the lungs, signifies the patients' lung is given “Time to Heal"®. This enables a paradigm shift in the treatment of respiratory failure: from prioritization of pulmonary gas exchange to true of lung protection. In the meantime this procedures has been established and the portfolio of products for the so-called "ultra-protective" ventilation is constantly growing. Although Novalung operates on an international level, "Made in Germany" applies hundred percent to the iLA Membrane Ventilator®. The complete value chain, research and development, production site as well as marketing is situated exclusively in Germany. | |||||||
| oekoservice GmbH | Biotech | Ecology/Environment | Development and construction of biological wastewater purification systems (B 2000, BioTop, BioTopp, sludge settling), biotechnological optimisation of the purification function of municipal wastewater treatment plants, plants for rainwater utilisation, and maintenance of small-scale wastewater treatment plants and separating plants. | Denkendorf | Gerlinde Zink, Managing Director Nicole Alderath-Zink, Assistant to the Managing Director Jürgen Zink, Technical Manager | 1984 | Köngener Strasse 14 73770 Denkendorf Germany Tel. +49 (0)711-934933-0 Fax: +49 (0)711-934933-21 | info@oekoservice.com | www.oekoservice.com | Ökoservice GmbH was founded in 1984. The company's core business includes plants for decentralised wastewater disposal (municipal wastewater treatment plants for 4 to 3000 residents), and industrial wastewater plants. A large number of plants based on the patented __B 2000__ system, the __BioTop__ system launched in 1997, and its improved successor the __BioTopp__ system are all successfully in service. The __BioTop__ and __BioTopp__ wastewater treatment plant systems are available in plastic or concrete configurations and in the form of a retrofit kit, which is also ideally suited for export. Ökoservice GmbH received a special recognition award at the "2005 Esslingen Innovation Prize" for its innovative combination comprising __BioTopp__ with no mechanical pre-treatment and a sludge settling system. The system does not process faecal sludge, which is relatively expensive when it comes to disposal, thereby ensuring full compliance with recycling management and waste disposal legislation. Rainwater utilisation plants are a further key area of environmental technology at Ökoservice. These can be adapted in the form of all-in-one systems to meet the requirements of private households and industry. The company's product portfolio also contains an extensive offering of separating plants for oil, petrol and fats. In addition to process development of wastewater purification systems, Ökoservice has performed maintenance on small-scale wastewater treatment plants for over 20 years and has a network of maintenance contracts across Germany. The company analyses wastewater samples in its own lab as evidence for the authorities. Furthermore, evaluations of analysis results are used to optimise the purification function. The maintenance programme also covers separating plant and pumping stations. | |||||||
| SMP GmbH | Medtech | Medical Technology | Service for medical products | Tübingen | Klaus Roth Dr. Ludger Schnieder | 2000 | Hechinger Strasse 262 72076 Tübingen Germany Tel. +49 (0)7071-857893-100 Fax +49 (0)7071-857893-200 | info@smpgmbh.com | www.smpgmbh.com | SMP GmbH was founded in 2000 from the PMP (Test Centre for Medical Products), however also became a new member of the PMP. Other members include the NMI Scientific and Medical Institute at the University of Tübingen in Reutlingen, the Section for Minimally Invasive Surgery and the Institute for Clinical Hygiene at the University Hospital Tübingen. SMP GmbH concentrates on applying the test methods developed at the PMP, in particular the radionuclide method, which can be used to validate the cleaning of medical products. SMP GmbH also specialises in the sterilisability of medical products with damp heat or hydrogen peroxide plasma (ASP Johnson & Johnson method) and services for evaluating prion decontamination on surgical instruments. In addition, SMP GmbH coordinates Cleantest, an EU-sponsored research project involving several European companies and institutes. The project aims to validate a cleaning process for minimally invasive surgical instruments and develop a monitoring system. | |||||||
| The Microarray Facility | Biotech | Medicine, Diagnostics | Analyses with DNA chips | Tübingen | Dr. Michael Bonin (CEO) | 2001 | Medizinische Genetik Calwerstrasse 7 72076 Tübingen Germany Tel.: +49 (0)7071-2972295 Fax: +49 (0)7071-295172 | michael.bonin@microarray-facility.com | www.microarray-facility.com | The Microarray Facility at the University of Tübingen specialises most notably in providing services based on Affymetrix GeneChip® technology. Microarrays have a versatile range of diagnostic uses. The Microarray Facility diagnostic tools include the Roche AmpliChip which has been approved by the US FDA as a tool for in vitro diagnosis to examine 33 different alleles of the cytochrome P450 enzymes 2D6 and 2C19. Doctors can then use the result to adjust the individual dose of drugs where the two enzymes are involved. The Affymetrix CustomSeq® resequencing array, which enables analysis of the CFTR gene, can be used to help diagnose cystic fibrosis, a commonly autosomal recessive hereditary disorder. Oligonucleotide arrays have a number of applications, including genetic coupling or association studies and the detection of chromosomal defects. | |||||||
| Institut Dr. Lörcher | Biotech | Chemistry, Ecology/Environment | Chemical and microbiological analytics | Ludwigsburg | Dr. Klaus-Peter Lörcher | 1979 | Martin-Luther-Str. 26 D-71636 Ludwigsburg Tel.: +49 (0)7141-975700 Fax: +49 (0)7141-9757070 | www.loercher.de | Dr. Klaus-Peter Lörcher established his institute in Ludwigsburg in 1979 with authorisation from the Stuttgart Region Chamber of Commerce and Industry for analytical chemistry, water, wastewater and waste chemistry. Dr. Lörcher’s institute specifically focuses on chemical analytics, organic trace analysis, dioxin and metal analysis, swimming pool, compost and solid matter analytics, microbiology, indirect discharger cadastre and compartment air analyses, landfill surveillance, quality control of sewage sludge, expert opinions on fire loss, house and commercial waste to name just a few of the analyses offered. In early 2008, Dr. Lörcher was accredited by DIN CERTCO Gesellschaft für Konformitätsbewertung mbH, which has enabled him to carry out assessments into the environmental effects of synthetic turf, plastic coating for outdoor sports grounds and the investigation of wood pellets made of unchanged natural wood for use in small fireplaces. | ||||||||
| rent-a-lab Dr. Carsten Tober | Biotech | Laboratory Techniques | CRO for radioactive bioassays: GPCR pharmacology, receptor binding studies, receptor mutation studies, in vivo-occupancy, enzyme assays, RIAs | Reutlingen | 2003 | Aspenhaustrasse 25 72770 Reutlingen Germany Tel.: +49 (0)7121-515367-0 Fax: +49 (0)7121-515367-9 | info@rent-a-lab.biz | www.rent-a-lab.biz | rent-a-lab is a contract research organisation (CRO) providing services mainly in the field of radioactive bioassays (isotopes: [3H], [125I], [14C], [35S], [33P] and [32P]). Services are customised to meet specific needs reaching from individual small scale solutions (e.g. execution of radioimmunoassays (RIAs) or enzyme assays) to assay development for new targets and medium-throughput screening (MTS) of test compounds. rent-a-lab is also able to generate transiently transfected cell lines (CHO, HEK) for receptor mutation studies. One main focus of rent-a-lab is the pharmacology of G-protein-coupled receptors (GPCRs), in this research area several functional assays are offered (e.g. [35S]GTPγS binding tests, adenylate cyclase assays, Gα-subtyp-specific assays). rent-a-lab produces and sells also membrane fragments (e.g. of pig brain). Currently rent-a-lab develops a method to produce pancreatic islets. | ||||||||
| Biodegma GmbH Gesellschaft für umwelttechnische Anlagen und Verfahren mbH | Biotech | Ecology/Environment, Laboratory Techniques | Mechanical and biological waste treatment, composting | Ludwigsburg | Reiner Glock Bernd Jörg Ralf Müller | Martin-Luther-Strasse 26 71636 Ludwigsburg Germany Tel.: +49 (0)7141-688880 Fax: +49 (0)7141-6888825 | info@biodegma.de | www.biodegma.de | Biodegma GmbH supplies products and services for the mechanical and biological treatment of waste, on-floor (hire system) ventilation and composting. | ||||||||
| BioLux GmbH | Biotech | Trade/Distribution, Genomics | Genetic analysis and synthesis | Stuttgart | Dr. Klaus Höhnel (CEO) | Brommerstrasse 19 70563 Stuttgart Germany Phone: +49 (0)711-9018185 Fax: +49 (0)711-9018187 | info@biolux-biotech.com | www.biolux-biotech.com | Stuttgart-based BioLux GmbH operates a molecular biological laboratory. The company performs private paternity tests using DNA isolated from samples taken from the lining of the mouth. The BioLux service portfolio also includes DNA sequencing, Edman protein sequencing, peptide and artificial gene synthesis, and the production of polyclonal antibodies from rabbits and chicken eggs (contract immunisation). BioLux works closely with French company Genosphere Biotechnologies, based in Paris. BioLux also develops and markets the test systems of Slovakian company Dolfin for the detection of C. burnetii and Chlamydophila psittaci antibodies in biological samples. | ||||||||
| Chemical and Veterinary Investigation Office Stuttgart | Institute | Ecology/Environment | Investigation office focusing on food safety and animal health | Fellbach | Maria Roth | Schaflandstraße 3/ 2 und 3/ 3 D-70736 Fellbach P.O.1206 D-70702 Fellbach | Poststelle@cvuas.bwl.de | www.cvuas.de | The Chemical and Veterinary Investigation Office (CVUA) Stuttgart is one of four state investigation offices in Baden-Württemberg focusing on food safety and animal health. The CVUA in Stuttgart has 200 employees, including food chemists, veterinarians, biologists and technical staff who investigate approximately 24,000 products for harmful substances and around 117,000 animal samples for health risks/diseases per year. Besides the investigation of food and animals, the CVUA Stuttgart also offers consultation services to public authorities and state institutions relating to food monitoring and the control of animal diseases as well as organising additional training events and consulting services for producers and sellers of food or utensils. The CVUA Stuttgart has 7 departments that are housed in two buildings with 4,500 m2 of laboratory space and 1,700 m2 of office space. | ||||||||
| German Centre for Biomaterials and Organ Replacement | Institute | Development, Regenerative Biology, Process Engineering | Development of biomaterials and organ replacements | Denkendorf | Prof. Dr. Ing. H. Planck (Chairman) Prof. Dr. med. H.D. Becker (Vice Chairman) Prof. Dr. human. biol. Lutz Claes (Secretary) Prof. Dr. med. Karl-Klaus Dittel (Auditor) Dr.-Ing. Martin Dauner (Coordinator) | Körschtalstr. 26 D-73770 Denkendorf Tel: +49(0)711-93400 Fax:+49(0)711-9340297 | bmoz@itv-denkendorf.de | www.itv-denkendorf.de | The German Centre for Biomaterials and Organ Replacement Stuttgart-Tübingen (BMOZ) brings together the scientific and clinical institutions of the universities of Stuttgart and Tübingen and is being funded by the German Federal Ministry of Education and Research (BMBF) for a period of five years as part of the “Ma-Tech” programme. BMOZ has obtained additional financial support from the Baden-Württemberg Ministry of Science, Research and the Arts, the University of Tübingen and project-related industry funds. BMOZ’s main activity is the coordination of research projects funded by the BMBF and its industrial partners. The goal of the Centre is to give industry a basis for the concerted development of biomaterials and organ replacements. Besides basic research, the partners are therefore mainly focused on application-oriented developments in cooperation with pharmaceutical and medical device companies. The Centre’s activities are: * Design and development planning * Polymer synthesis and processing * Surface modification (plasma, wet, biochemistry) * Implants & instruments: development / production * Purification and sterilisation methods * Pharmacological studies * Tissue engineering * Testing (biomechanical, physical-chemical, biological) * In vivo animal studies * Clinical trials The laboratories of the research institutes that are part of BMOZ (ITV, IGB, NMI) along with the animal experiment institute at the University of Tübingen are all accredited by the Zentralstelle der Länder für die Gesundheit (ZLG) for the medical product area. | ||||||||
| IDENTXX GmbH | Biotech | Development, Ecology/Environment | Early detection of infected seeds using DNA probe technology | Stuttgart | Frank Brändle (Managing Director) | IDENTXX GmbH Maybachstrasse 50 70469 Stuttgart Pflanzenschutz FON +49 (0)711 93343651 Herbologie FON +49 (0)711 93343653 Labor FON +49 (0)711 93343654 FAX +49 (0)711 93343659 | info@identxx.de | www.iden | With state-of-the-art biomolecular methods the young company IDENTXX meets the challenge to sustain and improve crop health. Only an exact and reliable identification of pathogens and resistances in seeds and plants can avoid crop damage and yield losses. IDENTXX develops tailor-made solutions in diagnostics for weed science and plant protection. Our services focus on the detection of plant pathogens and herbicide resistances, for which the latest biomolecular methods are applied. The methods are individually and continuously adapted to the problem at hand. The services of IDENTXX benefit clients in the sectors of agricultural production of arable and special crops as well as ornamentals. It may play a key role in improving seed production, plant breeding, development of plant protection products, and is targeting agricultural associations and public authorities. IDENTXX runs its own brand-new laboratory and greenhouses under the direction of experienced specialists. Hence, it enables the application of the latest biomolecular technologies in combination with classical greenhouse testing. | ||||||||
| Life Science Center Hohenheim (LSC) | Institute | Development, Genomics | Life sciences research with a special focus on the food chain – from production to consumer behaviour, as well as biological signals. | Stuttgart | Prof. Dr. Andreas Schaller (Director) Dr. Caroline Liepert (Managing Director) Prof. Dr. Andreas Kuhn (Spokesperson Division 1) Prof. Dr. Herbert Schmidt (Spokesperson Division 2) Prof. Dr. Thilo Streck (Spokesperson Division 3) | Fruwirthstraße 12 D-70599 Stuttgart Tel.: +49 (0)711-45924026 | lsc@uni-hohenheim.de | www.lsc.uni-hohenheim.de | The Life Science Centre (LSC) is a research centre attached to the University of Hohenheim that is directly assigned to the University’s rectorate. It offers life science-oriented disciplines a central platform for research projects and scientific developments. The LSC has a special focus on the food chain and hopes to advance its work through inter- and transdisciplinary approaches. In addition, the Centre also supports bordering basic-research oriented sciences, in particular in the field of biological signals. In analogy to the thematic research priorities of the Centre, the LSC has three scientific divisions: Division 1: Biomolecular signals and genomics Division 2: Quality and biofunctionality of food Division 3: Ecosystems and resource management The LSC has a central service unit that uses state-of-the-art methods and devices for genome and proteome analysis. | ||||||||
| science + computing ag | Biotech | Information Technology | services in the field of IT systems | Tübingen | Dr. Ingrid Zech, Dr. Arno Steitz (Directors with representative authority) | Hagellocher Weg 73 72070 Tübingen Phone: +49 (0)7071-9457-0 Fax: +49 (0)7071-9457-211 | info@science-computing.de | www.science-computing.de | science + computing ag offers IT services and software for the efficient utilisation of computer systems in research and development and has 18 years’ experience on the technical computing market (CAD, CAE, CAT). science + computing ag ensure that IT infrastructures are efficient, cost-effective and fail-safe so that customers can concentrate fully on their core business. | ||||||||
| Sohena GmbH | Biotech | Chemistry, Laboratory Techniques | Contract synthesis, contract research, analytics and syntheses development consulting | Tübingen | Heike Sowinski Ulrich Heber Stefan Narr | Auf der Morgenstelle 18 72076 Tübingen Germany Tel.: +49 (0)7071-2976249 Fax: +49 (0)7071-295386 | kontakt@sohena.de | www.sohena.de | Sohena GmbH offers a range of contract synthesis, contract research and analytics services. The company's main areas of focus include substance classes such as isomer-pure components, aromatic and acyclic substance classes and carbohydrates and glycopeptides. In addition, the company develops analytical and test methods and stability and degradation studies. Building on these services, the company also offers a comprehensive consulting service for synthesis planning and development. | ||||||||
| Transgenic Facility Tübingen, IZKF Service Transgenic Animals | Institute | Genomics | Service facility for the generation of transgenic animal models | Tübingen | Dr. Thomas Ott (Director) | Forschungsverfügungsgebäude der Medizinischen Fakultät Universitätsklinikum Tübingen Otfried-Müller-Str. 27 D-72076 Tübingen Tel.: +49 (0)7071-2972280 and 2972300 | thomas.ott@uni-tuebingen.de | www.medizin.uni-tuebingen.de | The Tübingen Transgenic Facility focuses on the generation of transgenic animal models with the aim of gaining insights into human hereditary diseases. Transgenic rats and mice are produced by injecting DNA into the pronucleus of zygotes and by the specific manipulation of genes in embryonic stem cells. The service laboratory also provides a service that generates knock-out and knock-in mice through the injection of embryonic stem cells into blastocysts. The facility’s services are complemented by planning advice and support for the production of genetically modified embryonic stem cell lines (knock-out and knock-in embryonic stem cell lines) as well in the planning of projects, including the preparation of applications for use with experimental animals. | ||||||||
| Centre for Regenerative Biology and Regenerative Medicine, ZRM | Institute | Development, Regenerative Biology, Education | Support of regenerative biology and medicine projects | Tübingen | Managing Director: Prof. Dr. Thomas Skutella Deputy Managing Director: Prof. Dr. Wilhelm K. Aicher Coordinator/CEO: Prof. Dr. Konrad Kohler | Paul-Ehrlich-Straße 15 D-72076 Tübingen Tel.: +49 7071 29-85034 Fax: +49 7071 29-4553 | info@regmed.uni-tuebingen.de | www.regmed.uni-tuebingen.de | The Centre for Regenerative Biology and Medicine zrm is a joint facility of the University Hospital Tübingen and the School of Medicine of the Eberhard Karl University of Tübingen. The centre supports projects in the fields of regeneration biology and regenerative medicine from basic research to clinical application. Major foci are stem cell research, cell therapy and the development of molecular regenerative strategies and biomaterials. The zrm develops and coordinates courses and seminars and offers a wide spectrum of services to its partners in the Regenerative Medicine network, ranging from consulting and assistance with projects to access to human cell and tissue banks. While consulting and networking services are provided free of charge by the centre, services involving a greater investment in time and material are usually charged. The members of the zrm come from biology and medicine departments of the University of Tübingen and the University Hospital. Scientists and physicians cover the entire spectrum of expertise from basic research to clinical research all the way to therapeutic application. The zrm comprises the following institutions at the University of Tübingen: * Anatomical Institute, Department of Experimental Embryology and Tissue Engineering * University Hospital of Tübingen, Department of General, Visceral and Transplantation Surgery * University Hospital of Tübingen, Department of Dermatology * University Hospital of Tübingen, Internal Medicine I * University Hospital of Tübingen, Internal Medicine II * University Hospital of Tübingen, Internal Medicine III * University Children’s Hospital Tübingen, Department I (General Paediatrics, Haematology, Oncology) * Clinic for Neurology, Department for Neurodegenerative Disorders * University Hospital of Tübingen, Hospital of Neurosurgery * University Hospital of Tübingen, Orthopaedic Clinic * University Hospital of Tübingen, Hospital of Radiology, Division for Diagnostic Radiology * University Hospital of Tübingen, Department of Radiation Oncology * Institute of Clinical and Experimental Transfusion Medicine * University Hospital of Tübingen, Department of Thoracic, Cardiac and Vascular Surgery * University Hospital of Tübingen, Clinic for Urology * University Hospital of Tübingen, Centre of Dentistry, Oral Medicine and Maxillofacial Surgery * University Hospital of Tübingen, Institute of Medical Microbiology and Hygiene | ||||||||
| JatroSolutions GmbH | Biotech | Development, Ecology/Environment | Development of concepts for the integrated production of biofuels and animal feed on waste land | Stuttgart | Prof. Dr. Klaus Becker (Managing Director) Dr. George Francis (Director of Research and Business Development) | Wollgrasweg 49 70599 Stuttgart-Hohenheim Tel.: +49 (0)711-451071420 Fax: +49 (0)711-451071421 | www.jatrosolutions.com | The company’s key focus area is Jatropha curcas, an oil seed plant that is indigenous to almost all tropical countries and that grows on poor soils in extreme climatic conditions. Due to its versatility, the plant is well suited to the production of biofuels, the recultivation of waste land, CO2 sequestration as well as to the creation of local jobs and income. JaotroaSolutions develops concepts for sustainable development in the tropics and subtropics as well as offering comprehensive process-oriented consulting and supporting the development of international trade relationships. | |||||||||
| Ocuserv GmbH | Biotech | Medicine | Opthamology services | Tübingen | Jasminweg 23 72076 Tübingen Germany Tel.: +49 (0)7071-650513 Fax: +49 (0)7071-650515 | office@ocuserv.de | www.ocuserv.de | The company offers a range of services based on its expertise in clinical and scientific opthamology. Its service portfolio ranges from organising courses and conferences, coordinating research projects, developing databases, preparing scientific reports and other documentation, researching and developing processes and equipment right through to ophthalmological diagnostics and treatment. | |||||||||
| Baden-Württemberg International | Service | Agency for International Economic and Scientific Cooperation | Stuttgart | Dr. Michael Magenmeyer (CEO) Dr. Herbert Neuland (Managing Director) Ulrich Mack (Member of Board of Management) Herbert Bossinger (Member of Board of Management) | Haus der Wirtschaft Willi-Bleicher-Str. 19 D-70174 Stuttgart Tel.: +49(0)711-22787-0 Fax: +48(0)711-22787-22 | info@bw-i.de | www.bw-i.de, www.bw-invest.de | Baden-Württemberg International was established in 1984 as the ”Baden-Württemberg Export Foundation ”(Exportstiftung Baden-Württemberg) in order to provide support to small- and medium-sized enterprises for foreign market entry. In 2004, in addition to developing and working with international business contacts, setting up and dealing with international projects, marketing the region as a business hub, and encouraging companies to locate in the area, bw-i broadened its focus to include science, research and the arts at the same time as changing its name to Baden-Württemberg International. Baden-Württemberg International’s activities include initiating international cooperation through programmes aimed at penetrating key markets across the globe. bw-i also promotes Baden-Württemberg as a business, education, and research centre – both at home and abroad. In addition, bw-i offers advice and assistance to foreign companies wishing to invest in Baden-Württemberg and organises projects in selected countries. Baden-Württemberg International is also the central contact for companies in Germany and abroad. The mission of Baden-Württemberg International is to optimally position Baden-Württemberg in a globally competitive market as a location for business and research and to promote the opening of foreign markets for enterprises from within the state. | Ernst Pfister, MdL (Chairman of Supervisory Board, Baden-Württemberg Minister of Economics) | ||||||||
| Centre of Competence Minimally Invasive Medicine & Technology Tübingen - Tuttlingen (MITT) | Service | Consultation services for companies, physicians, inventors and research institutes | Tübingen | PD Dr. Ludger Schnieder (Managing Director, Tübingen Office) Dr. Theophil Rieger (Project Manager, Tuttlingen/Neuhausen Office) Members of the Board: Prof. Dr. med. Claus Claussen (Chairman) Dr.-Ing. Klaus M. Irion Prof. Dr.-Ing. Heinrich Planck Prof. Dr. med. Diethelm Wallwiener Dipl.-Ing. Egon Warfia Dieter Heiss Prof. Dr. med. Arnulf Stenzl | Tübingen office Hechinger Straße 262 D-72072 Tübingen Tel.: +49(0)7071-857893112 Tuttlingen office Gewerbepark Take-Off 3 D-78579 Neuhausen ob Eck Tel.: +49(0)7467-910785 | info@mittev.de | www.mittev.de | MITT offers both its members and non-members targeted consultation on issues in the medical technology area. MITT’s goal is to intensify the transfer of knowledge between small trades, industry and science, something that is highly important in the field of medical technology. The MITT competence centre offers its services to all medical device companies and research institutions. Important consultation topics are issues related to knowledge and technology transfer, education and training, as well as economic issues that typically arise in medical device companies. The service spectrum also includes the arrangement of contacts between parties interested in carrying out joint projects, research and analyses on medical technology issues, support for matters relating to product approval and patent applications, as well as project financing through the introduction of recipients to investors and through the acquisition of funding. At present around 70 companies, research institutes and private individuals are members of the association. | Prof. Dr. med. Dietrich Grönemeyer (Chairman) Paul Seiler Prof. Dr. med. Hans-Peter Bruch Sven Behrens Rüdiger Strehl Dr. Christopher Herrmann Uwe Petersen | ||||||||
| NMI Natural and Medical Sciences Institute | Institute | Transfer of research results to industry, Transfer of research findings to the business sector | Reutlingen | Prof. Dr. Hugo Hämmerle (Managing Director) Dr. Alfred Stett (Deputy Managing Director), Prof. Dr. Hugo Hämmerle (Director) Dr. Alfons Stett (Deputy Director) | 1985 | Markwiesenstr. 55 D-72770 Reutlingen Tel.: +49 (0)7121-515300 Fax: +49 (0)7121-5153016 , Markwiesenstrasse 55 72770 Reutlingen Germany Tel.: +49 (0)7121-515300 Fax: +49 (0)7121-5153016 | info@nmi.de, info@nmi.de | www.nmi.de, www.nmi.de | The NMI was founded in 1985 as a non-profit foundation under civil law. The foundation comprises 12 mostly small- to medium-sized companies as well as the city of Reutlingen. A board of trustees, which is made up of representatives from research and industry, the Ministry of Economic Affairs and the Ministry of Science, Research and the Arts (Baden-Württemberg), oversees the institution. The NMI’s objective is the successful transfer of research findings to the world of business. The NMI covers the following core areas of activity: pharmaceutical and biotechnology research, biomedical technology and surface technology. The scientists who work within the NMI’s 16 research groups are among the pioneers of groundbreaking technologies and are internationally renowned for their innovations and patents. It was here, for example, that micro-electrode arrays (MEAs) were developed. These arrays are used to determine the effects of substances on cardiac muscle and nerve cells. The system was further developed by MCS Multi Channel Systems in Reutlingen and is now marketed worldwide. In conjunction with industrial partners and publicly-funded research institutions, the NMI is also involved in the development of tests based on protein or peptide arrays. In future, these systems will play an important role in diagnostics. By miniaturising and parallelising test systems (microarray technology), numerous parameters can be determined simultaneously in the smallest sample volumes. The use of protein arrays increases the speed of tests and results in a dramatic reduction in the cost of diagnostics, as it is possible to analyse several hundred parameters in a single experiment. Working with other companies, the NMI also initiates projects for the optimisation and further development of implants and surgical instruments. These consortia enable small- and medium-sized companies to take part in research projects under the Institute’s guidance, without having to provide the necessary equipment or scientific expertise themselves. They can access the NMI’s technologies, systems and services, including equipment such as the “Focused Ion Beam”, which enables material samples in the nanometer range to be mapped and prepared. With this latest advancement of the scanning ion microscope, companies from the fields of medical technology and the automotive industry are investigating functional flaws in semiconductor chips, the failure of coatings or instances of corrosion damage. The NMI also operates a comprehensive database (www.biochipnet.com) that is available for biotechnology companies, research institutions and service providers free of charge., NMI was founded in 1985 as a non-profit-making foundation under civil law. The foundation includes 12 mostly small to medium-sized companies and the City of Reutlingen. A board of trustees, which is made up of representatives from research and industry, the Ministry of Economic Affairs and the Ministry of Science and Research (Baden-Württemberg), oversees the institution. The NMI’s objective is to successfully transfer research findings to the world of business. The NMI is an established figure in its core areas of activity, namely: pharmaceuticals and biotechnology, biomedical technology and surface technology. The scientists, who work within the NMI in 13 working groups, are among the pioneers of groundbreaking technologies and are renowned internationally for their innovations and patents. It was here, for example, that micro-electrode arrays (MEAs) were developed. These are used to determine the effects of substances on cardiac muscle and nerve cells. The system was developed further by MCS Multi Channel Systems in Reutlingen and is marketed worldwide. In conjunction with industrial partners and publicly-funded research institutions, the NMI is also involved in the development of tests based on protein or peptide arrays. These systems will in future play an important role in diagnostics. By miniaturising and parallelising testing systems (micro-array technology), a range of measuring parameters can be determined simultaneously in even the smallest sample volumes. The use of protein arrays increases the speed of tests and results in a dramatic reduction in costs for diagnostics, since several hundred measuring parameters can be captured in a single experiment. Working with other companies, NMI also initiates projects for the optimisation and further development of implants and surgical instruments. These consortia enable small and medium-sized companies, under the Institute’s guidance, to take part in research projects without having to come up with the necessary equipment or scientific expertise themselves. They can access the NMI’s technologies, systems and services, such as the “Focused Ion Beam”, which enables material samples in the nanometer range to be mapped and prepared. With this latest further development of the scanning ion microscope, companies from the fields of medical technology and the automotive industry are investigating functional flaws in semiconductor chips, the failure of coatings or instances of corrosion damage. The firm also operates a comprehensive and freely-accessible BioChip database (www.biochipnet.com) for biotechnology companies, research institutions and service providers. | Dr. Nadja Gugeler – Public Relations (gugeler@nmi.de), Dr. Nadja Gugeler - Marketing (gugeler@nmi.de) | ca. 130, Approx. 100 | Postgenomic Screening Platform – modular technology platform for complex biological assays – in conjunction with EDI and accelab GmbH | Joint research project: Bio-reabsorbable collagen fibres for nerve regeneration. Joint research project: Bio-artificial surface substitute for the treatment of degenerative cartilage diseases; subproject 3 | ||||
| 4base lab GmbH | Biotech | Service provider in the field of genomics and proteomics; GMP analyses | Reutlingen | Dr. Despina Tougianidou Dr. Thomas Maier Dr. Manfred Bayer | 1995 | Aspenhaustrasse 25 72770 Reutlingen Germany Tel.: +49 (0)7121-937557 Fax: +49 (0)7121-937558 Postal Adress: Postfach 4023 72771 Reutlingen Germany | info@4base-lab.de | www.4base-lab.de | 4base lab GmbH was founded in 1996 and provides services in the field of genome and proteome analysis. These include DNA sequencing, protein analysis (N-terminal sequencing, Edman degradation, MALDI-ToF analysis), the production of BAC and PAC clones, gene expression analysis, in vitro mutagenesis, mRNA 5’ mapping, polymerase chain reaction (PCR) analysis and cloning. In the R&D sector, 4base lab primarily focuses on the development of assays for detecting viral pathogens. Quality assurance is carried out based on ISO 9001 standards for medical products, foodstuffs and life science consumables. Drug testing involving DNA sequencing and real-time PCR is carried out in compliance with GMP standards. 4base lab GmbH has also developed the first CE-labelled test kit for the detection of all influenza A group viruses, which also includes the bird flu virus. | Birgit Blum (office@4base-lab.de) | 8 | The company holds the ISO 9001 certificate and is certified to carry out DNA sequencing and real-time PCR under GMP conditions. | Development of assays for the detection of viral pathogens | ||||
| EDI GmbH | Biotech | Commissioned research for the pharmaceutical, cosmetic and chemical industry. The effects of substances are checked on the human immune systems under in vitro conditions similar to those in vivo. | Reutlingen | Dr. Manfred Schmolz (Edigmbh@aol.com) | 1996 | Aspenhaustr. 25 72770 Reutlingen Germany Tel.: +49 (0)7121-434103 Fax: +49 (0)7121-491074 | info@edigmbh.de | www.edigmbh.de | EDI GmbH, acquired by Rules Based Medicine Rules, Inc. (RBM), a leading multiplexed biomarker testing laboratory for the life sciences industry in October 2007, offers commissioned research in the field of immunopharmacology, immunotoxicology and cell biology, together with commissioned development work and the validation of customised cell culture systems, but also immunoassays of all kinds. One key area of focus in the field of pharmacological assays is substance screening and the profiling (= characterisation) of active agents on a testing platform involving human, organotypical test cultures (HOT Screening and HOT Profiling). These permit a very complete picture of the main and side effects of active agents to be built up in vitro in a way that has never before been possible. This means that, from a series of comparable leads or drug candidates, the active compounds that demonstrate the most advantageous spectrum of effectiveness and the lowest probability of unwanted side effects can be specifically selected for further development or the clinical testing phase. For clinical trials, EDI GmbH has also developed a patented method that enables functional tests on the human immune system to be carried out at very low cost with hitherto unparalleled levels of reliability and sensitivity. The firm’s portfolio of services also includes the drafting of development plans, testing outlines and plans for clinical trials compliant with the German Drug Law (AMG), GCP etc., the creation of pharmacological-toxicological expert reports, medical writing, consulting in the context of immunological research and the coordination of accompanying experiments. The cellular tests carried out by EDI GmbH can be designed for use in pharmacological, toxicological or compatibility investigations. | Dr. Manfred Schmolz | < 10 | EN ISO 13485:2003 | |||||
| SHS Gesellschaft für Beteiligungsmanagement mbH | Service | Investment company | Tübingen | Dr. Bernhard Schirmers (Founder and Managing Director) Reinhilde Spatscheck (Founder and Managing Director) Hubertus Leonhardt (Partner and Managing Director) | 1993 | Bismarckstrasse 12 D-72072 Tübingen Tel.: +49(0)7071-91690 Fax: +49(0)7071-9169190 | tuebingen@shsvc.net | www.shsvc.net | SHS is an investment company providing venture capital to young technology companies. It also supports companies in the establishment and development phases. SHS invests in young, strong growth companies that are active in the life sciences/healthcare sectors (medical technology, diagnostics, biotechnology, pharma (not including drug development), platform and production technologies) in the German-speaking capital market. | 9 | |||||||
| Deutsches Erwachsenen Bildungswerk e. V. (DEB) | Service | Adult education | Fellbach | Adolf Erben (Chairman) Jacqueline Erben-Schmittfull (Managing Director) | Auberlenstr.13 70736 Fellbach Tel.: +49 (0)711-610610 Fax: +49 (0)711-6152119 | berufskolleg@deb.de | www.deb.de | The non-profit DEB Group works in the field of adult education. DEB has educational and vocational institutions in around 50 cities in eight German states. The private vocational college in Fellbach (near Stuttgart) trains chemical technicians (CTA), pharmaceutical technicians (PTA) and biotechnological technicians (BioTA). The courses last from 2 to 2.5 years. If there is sufficient interest in the required modules, the Fellbach college will also run courses that qualify students to apply to universities of applied sciences. The college in Fellbach currently has around 180 students in eight classes, who have theory and practical classes in traditional classrooms as well as in four large chemistry laboratories, a galenics and botany laboratory. A computer room is also at the students’ disposition. | Gabriele Ring-Preising | ||||||||
| Society for the Promotion of Biotechnology Stuttgart/Tübingen/Neckar-Alb | Service | Promotion of biotechnology in the Stuttgart/Tübingen/Neckar-Alb region | Tübingen | Prof. Dr. Claus D. Claussen (Chairman) | Paul-Ehrlich-Straße 15-17 72076 Tübingen Tel.: +49 (0)7071-689797 | info@biotechnologie-verein.de | www.biotechnologie-verein.de | The Verein zur Förderung der Biotechnologie Stuttgart/Tübingen/Neckar-Alb e.V. (Society for the Promotion of Biotechnology Stuttgart/Tübingen/Neckar-Alb) supports companies and research institutions in the STERN region in order to position the region as an outstanding biotechnology location in the long term. This involves the organisation of events such as the international BioStar Congress, which is held every two years in the STERN region, providing a forum for exchange and discussion for all key players and people interested in the field of regenerative biology. The Society is focused on linking up companies and institutions in the region. In order to promote networking activities, it organises regular meetings for its 90 members and all other people interested in biotechnology as well as numerous other events. It also publishes the “Biotech Regional” magazine several times a year. | Ursula Eising (eising@biotechnologie-verein.de) | ||||||||
| Steinbeis Beratungszentren GmbH | Service | Consulting for the industrial, service, trade & consumer goods, financial services, healthcare and the public sectors | Stuttgart | Dipl.-Wirtsch.-Ing. August Musch (Managing Director) | 2005 | Steinbeis Beratungszentren GmbH Haus der Wirtschaft Willi-Bleicher-Str. 19 70174 Stuttgart Tel.: +49 (0)711-18395 | beratung@stw.de | www.stw-beratung.de | Steinbeis Beratungszentren GmbH (SBZ) comprises more than 60 consulting centres, offering a broad range of consulting for virtually all business sectors. Our consulting centres bring together experts and experienced consultants from all areas of knowledge and management. Our consulting centres offer a comprehensive service and consulting portfolio to companies in all industrial sectors as well as to public players. Through our holistic solutions and consulting adapted to the specific requirements of individual clients, the Steinbeis consultants contribute to the clients’ successful business development. The consulting services comprise the following fields: strategy & organisation, production and process optimisation, marketing & sales, finance & controlling, personnel development & management, mergers & acquisitions, reports & expertise as well as interim management and business development. SBZ is part of the Steinbeis Foundation. | ||||||||
| BIOPRO Baden-Württemberg GmbH | Service | State-wide service agency providing targeted support to research institutions and companies in the biotechnology and life sciences sectors. | Stuttgart | Dr. Ralf Kindervater (CEO) | Breitscheidstraße 10 D-70174 Stuttgart Tel.: +49 (0)711-21818500 Fax: +49 (0)711-21818502 | info@bio-pro.de | www.bio-pro.de | At the end of 2002, the Baden-Württemberg government established BIOPRO Baden-Württemberg GmbH as a wholly owned affiliate for the promotion of biotechnology in the state. The 10-person team under the leadership of Dr. Ralf Kindervater provides support to research institutions and companies in the biotechnology and life sciences sectors. As Baden-Württemberg’s central point of contact for business development issues in the biotechnology and life sciences sectors, it is the task of BIOPRO Baden-Württemberg GmbH to optimally position the strengths of this leading biotechnology location on a national and international level at the same time as developing the location to ensure future sustainability. Specific business promotion measures help to secure know-how and jobs in the state as well as transferring the huge potential of innovative research to industrial applications. BIOPRO Baden-Württemberg GmbH’s broad public relations work involves the dissemination of information about this highly innovative cross-sectional technology. | |||||||||
| Biotechnologische Studenteninitiative (btS) e.V. | Service | Student initiative with the aim of intensifying contacts between universities and industry | Stuttgart | Stuttgart: Philipp Peterburs Roland Stork Peter Kaiser | Stuttgart Office Ludwig-Pfau-Straße 15/1 D-70176 Stuttgart Tel.: +49 (0)176-23957792 | vorstand.stuttgart@bts-ev.de | www.bts-ev.de | The Biotechnologische Studenteninitiative (Biotechnological Student Initiative) was established in 1996 in Cologne with the aim of intensifying contacts between universities and industry. The btS now has offices in 13 university cities, including Stuttgart, and is managed by a national board consisting of 5 members. In addition, the btS has four working groups covering events, Internet, sponsorship and public relations. The majority of btS members are active students from all disciplines. Students hoping to have a career in the life sciences, doctoral students who are about to start their careers or former students who are already working, all participate in the activities offered by the btS. The btS also works with professors who actively support the initiative with materials, rooms and consultation. An important part of btS is its collaboration with industry representatives, who act as speakers, arrange company visits and provide advertising and sponsoring resources. In addition, the btS organises evening lectures under the theme “University meets Industry” and arranges company visits as well as organising workshops for its members, panel discussions on current-interest topics and the “ScieCon” partnering fair. The btS office in Stuttgart works in cooperation with BioRegio STERN (www.bioregio-stern.de) to promote the foundation of start-up companies (Science2Start) and was also actively involved in organising the 2009 BIOSTAR Congress on Regenerative Biology and Medicine. The btS meets every other Thursday in the “Unithekle”, a pub on the Vaihingen university campus. | |||||||||
| EXZET Stuttgart - Centre for Company Foundation and Business Development | Service | Process-oriented start-up consulting | Stuttgart | Oliver Förster Rolf Dingethal | Standort Stuttgart: Heilbronner Straße 67 70191 Stuttgart Tel.: +49 (0)711-28446698 Fax: +49 (0)711-28446697 Standort Reutlingen: Tübinger Straße 61 (entrance through no. 63) 72762 Reutlingen Tel.: 07121-3843277 Fax: 07121-3843554 | office@exzet.de, Reutlingen@exzet.de | www.exzet.de | EXZET, Zentrum für Existenzgründung und Unternehmensentwicklung (Centre for Company Foundation and Business Development), has a team of experienced, self-employed consultants who prepare start-up companies and established companies in different industrial sectors for the potential activities and requirements in all economic and sociopsychological issues related to company establishment and development. EXZET offers individual consulting, special seminars and workshops. In close cooperation with different partners, EXZET works towards improved conditions for company founders in Germany. EXZET is accredited according to the quality standards for target-group-specific consulting set by the Deutsches Gründerinnen Forum (German Founder Forum). EXZET’s service spectrum includes all phases of company development. The company’s key competence is the development and provision of full service packages consisting of know-how, small loans and networking. EXZET’s modern network structure enables economic and sociopolitical interests to be seamlessly linked. Besides its partners, EXZET has a management board that is responsible for the management and organisation of the company. It is synonymous with lively vision, state-of-the-art leadership and management principles and efficient work- and project structures. | |||||||||
| Research Centre for Innovation and Service (FZID) | Institute | Support and promotion of research at the University of Hohenheim | Stuttgart | Prof. Dr. Stefan Kirn (Chairman of the Board) Prof. Dr. Hans-Peter Burghof (Vice-Chairman of the Board) Dr. Frank Kupferschmidt (Managing Director) | Universität Hohenheim Fruwirthstraße 12 Räume 232 und 234 70599 Stuttgart Tel.: +49 (0)711-45922476 | fzid@uni-hohenheim.de | www.fzid.uni-hohenheim.de | The Research Centre for Innovation and Service (FZID), founded in 2005, is one of five scientific centres at the University of Hohenheim. The FZID brings together the interdisciplinary research competences of Hohenheim economic and social scientists. Its major focus is innovation and service research at the University of Hohenheim. Research at the FZID focuses on innovation and knowledge, innovation systems and communication technologies, corporate finance and risk management, healthcare management as well as communication management. The FZID is currently establishing research areas in marketing and management, economics and sustainability and ethics. | |||||||||
| Hauswirtschaftlich-sozialpädagogische Schule (HWS) | Service | School education | Albstadt | Wolfgang Wunder (Headmaster) Gerhard Schweizer (Deputy Headmaster) | Johannesstraße 6 72458 Albstadt Tel.: +49 (0)7431-121151 Fax: +49 (0)7431-121158 | info@hws-albstadt.de | www.hws-albstadt.de | The HWS in Albstadt is a vocational school in Baden-Württemberg that specialises in housekeeping and social pedagogy. The school was established in 2004 as a result of the merger between the Friederike-Rösler School in Balingen and the Hauswirtschaftliche Schule Albstadt (housekeeping school in Albstadt). The school has 700 students, 70 teachers and 32 classes. The HWS offers 12 varied and interesting school types, including five in social pedagogy, which have led to the establishment of a regional social pedagogy competence centre in Albstadt. The grammar schools specialising in nutrition and biotechnology offer stimulating science-oriented courses. In addition, the school offers the possibility of pursuing a two-year vocational training course (Fachschulreife) and of attending different one-year full-time schools as part of the compulsory education requirements. The HWS Albstadt is a so-called OES – operatively independent school – school that participates in the Baden-Württemberg school development process. | |||||||||
| ifex – Initiative for Start-Ups and Business Transfer | Service | Supporting company foundations and securing company successions | Stuttgart | Prof. Peter Schäfer (Director) | Theodor-Heuss-Str. 4 D-70174 Stuttgart Tel.: +49(0)711-1232786 | ifex@wm.bwl.de | www.newcome.de, www.wm.baden-wuerttemberg.de | The Baden-Württemberg government sees the promotion of company foundation and the securing of company successions as central issues in its small- and medium-sized businesses policy. In 2001, the Baden-Württemberg parliament decided on the permanent continuity of the Initiative for Start-Ups and Business Transfer (ifex) following the recommendation of the “Mittelstand” survey committee. ifex has been run by the Baden-Württemberg Ministry of Economic Affairs since 1st July 2004 and is part of the “Start-up and Business Transfer / ifex" division (no. 33). ifex has a network of approximately 1400 institutions, chambers, associations, business development organisations, universities, schools, authorities and representatives from private companies. These cooperation partners and their innovative ideas contribute to the new company foundation culture. ifex has developed diversified information, qualification and consultation services. ifex initiates state-wide campaigns and competitions, new ways of assistance and concerted actions. Projects and partners are coordinated on the regional as well as international levels. In addition, ifex also supports information, qualification, consultation, coaching and target-group specific model projects and regional projects being carried out by partner organisations. | |||||||||
| Käthe Kollwitz School | Service | Education of schoolchildren | Esslingen | Thomas Fischle Roland Conradt | Steinbeisstr. 17 73730 Esslingen Tel.: +49(0)711-3607400 Fax: +49(0)711-3607444 | kks-es@web.de | www.kks.es.schule-bw.de | The Käthe Kollwitz School in Esslingen has around 800 pupils. The school brings together a large number of types of schooling under one roof, including a biotechnological grammar school, a grammar school focusing on nutrition, a vocational school focusing on nutrition and housekeeping, a dual vocational school focusing on social affairs (part-time) and two-year vocational schools (nutrition, gastronomy, nutrition and housekeeping, health and patient care, laboratory technology) as well as a vocational school focusing on housekeeping and social pedagogy. In the 2001/2002 school year, Baden-Württemberg was the first German state to take account of the growing importance of biotechnology at grammar schools, which led to the establishment of “biotechnological grammar schools.” The new course, as offered by the Käthe Kollwitz School in Esslingen, is designed to strengthen the profile of the natural sciences and to boost young people’s interest in biotechnology, a sector which looks to have a promising future. Biotechnology grammar schools offer a six-hour biotechnology profile course, which is complemented by bioinformatics, chemistry and special biosciences areas and practical courses. | |||||||||
| Medical Valley Hechingen Competence Network | Service | Strengthening medical technology companies | Hechingen | Hans Marquart (City of Hechingen Business Development) | Kompetenznetzwerk Medical Valley Hechingen c/o Büro des Bürgermeisters Marktplatz 1 72379 Hechingen Tel.: +49 (0)7471-940127 | buero.bm@hechingen.de | www.medical-valley-hechingen.de | The “Medical Valley Hechingen” competence network was launched by the mayor of Hechingen in 2002 as a joint initiative involving medical technology companies in Hechingen, Hirrlingen, Jungingen and Rangendingen. The network’s objective is to strengthen the power of innovation and the services and products offered by the region’s medical technology companies. The medical technology focus will in future be located in the “Naßwasen” (Hechingen North business park) industrial estate. At present, around 2,700 employees work in the medical technology companies in the Hechingen area. The companies employ a total of over 4,000 people worldwide. The competence network initiative was established with the support of the Neckar-Alb Regional Association (Regionalverband Neckar-Alb) and the ISW of the Steinbeis Foundation (Stuttgart). BioRegio STERN supports the competence network by promoting networking within the region and in particular cooperative projects with the biotech industry. Key medical technology products include medical instruments and devices for diagnosis and therapy, as well as disposable therapeutic products. All products are the result of intensive development work. The Medical Valley not only welcomes life sciences specialists. Outstanding software and electronics companies, equipment manufacturers and automation specialists are all major prerequisites for quick and efficient development and production. | |||||||||
| LBBW Venture Capital GmbH | Service | Provision of capital for start-up companies and expanding companies | Stuttgart | Harald Fuchs (CEO) | Königstraße 10 C D-70173 Stuttgart Tel.: +49(0)711-30589200 (switchboard) | Zukunft@lbbw-venture.de | www.lbbw-venture.de | LBBW Venture Capital GmbH is an investment company providing innovative companies with the economic framework for the growth of ideas and business models with a promising future. The company invests primarily in the fields of information technologies, innovative services, industrial technologies and life sciences. The geographic investment hotspot is southern Germany. The company provides financial support in the start-up, expansion and pre-IPO phases. The LBBW Venture Capital GmbH network includes specialised VC partners as well as specialist solicitors, auditors, and experts from a broad range of disciplines. | |||||||||
| Mathilde-Weber School | Service | Education in the fields of biotechnology, nutrition, floristics, health, social affairs, social pedagogy | Tübingen | Bernhard Kandler (Head of the school) | Primus-Truber-Strasse 39 D-72072 Tübingen Tel.: +49(0)7071-565160 | poststelle@mws.tue.schule.bwl.de | www.mws.tue.bw.schule.de | The Mathilde Weber School in Tübingen offers a broad range of schooling, including the possibility of obtaining a secondary general school certificate (Hauptschulabschluss), a secondary school certificate (Realschulabschluss) as well as an advanced technical college entrance qualification and the Abitur (university entrance diploma). In addition, the school also offers courses for accreditation as an educator or florist. Vocational training to obtain a bachelor’s degree in social work organisation and leadership and the acquisition of additional qualifications at the MWS vocational school is also offered. The MWS has two grammar schools, one focusing on nutrition and the other focusing on biotechnology. The nutrition-oriented grammar school teaches general education subjects along with nutrition and chemistry (6-hour profile course), data processing and economics. The biotechnology-oriented grammar school teaches general education subjects along with biotechnology (6-hour profile course), chemistry and special areas in the biosciences and bioinformatics. | |||||||||
| Esslingen Technical Academy (TAE) | Service | Professional training and education | Ostfildern | Dipl.-Ing. Hans-Joachim Mesenholl | An der Akademie 5 D-73760 Ostfildern Tel.: +49(0)711-340080 | info@tae.de | www.tae.de | The Esslingen Technical Academy (TAE) offers professional training and education for companies and their specialists and executives. With more than 2,000 speakers from the realms of business and science, TAE organises about 1,000 events per year. The quality of the professional qualification offered by the TAE is certified according to DIN EN ISO 9001. The TAE offers education and training in the following eight business areas: mechanical engineering, automotive and tribology, mechatronics and automation technology, electrical engineering and electronics, information technology, medical technology, construction engineering as well as business administration and individual work skills. The practical relevance and the concrete benefit for participants and companies are the most important aspect of the events organised. | |||||||||
| Proplanta GmbH & Co. KG | Service | Information services for the agricultural sector | Stuttgart | Dr. sc. agr. Jörg Mehrtens (Managing Director) | Wollgrasweg 49 D-70599 Stuttgart-Hohenheim Tel.: +49(0)711-451017610 Fax: +49(0)711-451017615 | mail@proplanta.de | www.proplanta.de | Proplanta GmbH & Co. KG is a media agency that acts as an independent information service provider for the agricultural sector, both in the print and online sector. The company’s services comprise, amongst other things, the preparation of agricultural papers, advice for agricultural monitoring studies, agricultural photo service (photo database: > 50,000 photos), planning and implementation of user-friendly IT solutions, search engine marketing, online geodatabase services, agricultural news service, agricultural ‘yellow pages’ and media data services. In addition, Proplanta also offers a job centre for the agricultural sector. | |||||||||
| scienceDISPLAY | Service | Professional representation of scientific topics | Tübingen | Dr. Bettina Danker | Dr. Bettina Danker Weizsäckerstr. 6 72074 Tübingen Tel.: +49 (0)7071-256335 | danker@science-display.com | www.science-display.com | scienceDISPLAY has extensive know-how in the professional representation of scientific topics and comprehensive experience in exact scientific illustrations. scienceDISPLAY creates virtual 3D models as well as graphics, animations, films and interactive presentations for advertising, fairs, Internet or educational purposes. Commercial homepages can be created using PHP and the MySQL database. Dr. Bettina Danker obtained her qualifications for research into scientific issues and their clear presentation as a scientist working in the fields of cell and developmental biology and molecular physiology. | |||||||||
| SIMT Stuttgart Institute of Management and Technology | Service | Business school for management and technology | Stuttgart | Prof. Dr. Dr. h.c. mult. Johann Löhn (Managing Director) President of the Steinbeis University in Berlin | Filderhauptstraße 142 70599 Stuttgart Tel.: +49 (0)711-4510010 | info@uni-simt.de | www.uni-simt.de | The Stuttgart Institute of Management and Technology (SIMT) is an international business school and advanced education institute of the Steinbeis University Berlin (SHB). In 1998, SIMT was founded on the initiative of a number of renowned global players headquartered in the Stuttgart area, among them Bosch, Daimler, Hewlett-Packard, Siemens and Trumpf. As an advanced education institute, SIMT offers postgraduate master’s programmes leading to MBA, MSc or MBE degrees. All SIMT master’s programmes focus on technology and innovation management as well as international management. All its degrees are recognised in Germany. The courses follow the concept of “Project Competence Projects”, which means the students work for a German or international company at the same time as pursuing their studies. | |||||||||
| Steinbeis-Europa-Zentrum (SEZ) | Service | Advice to companies, research institutions, universities and regional funding agencies on questions related to European research programmes and technology cooperations. | Stuttgart | Prof. Dr. Norbert Höptner (Director Steinbeis-Europa-Zentrum and Commissioner for Europe of the Minister of Economic Affairs of Baden-Württemberg) Dr. Petra Püchner (Head of SEZ Stuttgart) Dr. Jonathan Loeffler (Head SEZ Karlsruhe) | Haus der Wirtschaft Willi-Bleicher-Str. 19 D-70174 Stuttgart Tel.: +49(0)711-1234010 | info@steinbeis-europa.de | www.steinbeis-europa.de | The Steinbeis-Europa-Zentrum (SEZ) was established in 1990 on the initiative of the then Commissioner for Europe of the Baden-Württemberg Minister of Economic Affairs. It offers support to small- and medium-sized companies, universities and research institutions in Baden-Württemberg relating to European research programmes and technology cooperations. With offices in Stuttgart and Karlsruhe, the SEZ provides support in the selection of funding programmes, the preparation of funding applications and the carrying out of cross-border projects including the search for suitable partners, project management, technology transfer and the development of regional innovation strategies. The Steinbeis-Europa-Zentrum is the national contact for small- and medium-sized companies in Baden-Württemberg and acts on behalf of the German Federal Ministry of Economics and Technology. It also acts as EU information centre for all Baden-Württemberg universities on behalf of the Ministry of Science, Research and the Arts. Since 2008, the SEZ has been a partner in the European Commission‘s Enterprise Europe Network that has a total of around 600 partners in around 40 countries. The objective of the Network is to support companies in all matters related to Europe, innovation, research and technology transfer as well as promoting the use of the results of European research. The SEZ is a partner in a Baden-Württemberg consortium that also comprises Handwerk International, the Baden-Württemberg Ministry of Economic Affairs and seven chambers of industry and commerce. From 1995 to 2008, the SEZ – in its role as the Innovation Relay Centre Stuttgart – Erfurt – Zurich - was a partner in the former innovation relay centre network. | |||||||||
| T5 Interface GmbH | Service | Human resource management | Böblingen | Peter Linde Klaus-Peter Kaas Andreas Schambert | Bunsenstr. 22 D-71032 Böblingen Tel.: +49(0)7031-285190 Fax: +49(0)7031-2851919 | info@t5-interface.de | www.t5-interface.de | T5 Interface GmbH, established in 2000, advises and supports companies in human resource management. The company’s core competence is personnel marketing, including consulting for the establishment of efficient and modern personnel recruitment concepts, as well as direct headhunting and selection of academic experts and executives. T5 Interface organises individual recruiting and image events for companies as well as pan-regional recruitment fairs. The “T5 Job Messen” fairs, with a special focus on healthcare, are the top recruitment fairs in Germany, based on reputation. The company has an Internet job portal where it publishes specific job offers for experts and executives in scientific and technical areas. The electronic company portal provides detailed profiles of potential employers, thereby offering companies an ideal platform for employer branding objectives. | |||||||||
| TechnoStart GmbH | Service | Consulting company for investment funds | Ludwigsburg | Michael Mayer (Managing Director) | Martin-Luther-Str. 59 71636 Ludwigsburg Tel.: +49 (0)7141-971590 | office@technostart.com | www.technostart.com | We invest in very small companies with big potential. TechnoStart is an independent venture capital organisation that has been operating since 1991. Its initial investments in any company are clearly focused on early stage investments in university spin-offs in the fields of applied physics, life sciences, chemistry and new materials. Our investment team consists of natural scientists; our background in the natural sciences and engineering enables us to assess your business idea competently and quickly. The cross-sectional technologies in which we are interested, serve as platforms for other technologies or products. They have the potential to sustainably change our client’s method of operation. Sometimes we invest in the completion of the scientific aspect of a project with the goal of accelerating the subsequent establishment of the technology platform and its commercialisation through products. If your ”idea” fits into this framework, then you could benefit from our active management activities and know-how. If we invest in your company, we will assist you in the entire process associated with the establishment of your company. | |||||||||
| Technologieparks Tübingen-Reutlingen GmbH (TTR) | Service | Operation and management of the Tübingen-Reutlingen Technology Parks | Reutlingen | Thomas Dephoff (Managing Director) | Gerhard-Kindler-Straße 8 D-72770 Reutlingen Tel.: +49(0)07121-9097990 | info@ttr-gmbh.de | www.ttr-gmbh.de | Technologieparks Tübingen-Reutlingen GmbH (TTR) is a wholly-owned subsidiary of L-Bank. The goal of TTR GmbH is to create an environment that makes it simpler and quicker to transfer ideas and introduce new products to the market. The TTR management team provides advice and looks after its clients from the word go. It also looks after the smooth operation of the park and associated buildings. TTR is represented at two sites, Tübingen and Reutlingen. In Tübingen, the major focus is biotechnological research, in Reutlingen the focus is the development of high-technology products. Both locations have buildings and special properties that can be adapted to the different technological requirements of potential tenants. In Germany’s biggest biotechnology start-up centre, TTR offers large laboratory and office areas that also allow for future expansions. | |||||||||
| Technology Transfer Office at the University of Tübingen | Service | Cooperation between industry and science | Tübingen | Dr. Rolf Hecker | University of Tübingen Zentrale Verwaltung Dez. VI.5 Technologietransfer Wilhelmstrasse 5 D-72074 Tübingen Tel.: +49(0)7071-2972639 | r.hecker@uni-tuebingen.de | The Technology Transfer Office at the University of Tübingen provides information, advice and support for all questions related to the collaboration between industry and science. The office arranges research contracts between the university and industry and licenses technologies developed at and property rights owned by the University of Tübingen. The University of Tübingen website gives an overview of its departments and institutes, the organisational structure of the faculties and its research priorities. | ||||||||||
| Patent Information Centre | Service | Services related to industrial property rights | Stuttgart | Regierungspräsidium Stuttgart Informationszentrum Patente Haus der Wirtschaft Willi-Bleicher-Str. 19 D-70174 Stuttgart Tel.: +49(0)711-1232558 | info@patente-stuttgart.de | www.patente-stuttgart.de | The spectrum of services offered by the Patent Information Centre ranges from the provision of comprehensive neutral information up to qualified consultation. Modern workstations with access to up-to-date property rights databases are available for visitors’ use. The centre’s staff offers support to users looking for patents, utility models, brands and industrial designs. These services are complemented by contract searches in chargeable databases and delivery services for property rights documents. In addition to initial consultation, the centre also offers short weekly consultations on all industrial property rights free of charge and in cooperation with patent attorneys from the region. Regular talks, patent research seminars and workshops and the “Tag der gewerblichen Schutzrechte” conference provide both first-time users and experts with useful information and training. On behalf of the German Patent Office, the centre accepts patent, utility model, brand and industrial design applications as well as European and international patent applications in due time. The centre is a useful point of contact in Baden-Württemberg for SMEs and scientific institutions that are new to industrial property rights or for start-up companies looking for a company name. |
